GlassScriptPhysician profile
Mahmoud Moghaddami
NPI 1659776557
$4,586.63
in general payments reported to CMS, 2019-2025
13 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,070 · 2022: $1,283 · 2023: $870 · 2024: $620 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,122 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,122.30 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,348.40 | 2021-2025 | |
| Almatica Pharma LLC | $738.34 | 2021-2025 | Loreev Xr, Sertraline Hcl |
| Takeda Pharmaceuticals U.S.A., INC. | $514.48 | 2021-2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $511.57 | 2021-2025 | Caplyta |
| Alkermes, INC. | $338.53 | 2021-2023 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $270.70 | 2022-2024 | Invega |
| Teva Pharmaceuticals USA, INC. | $262.29 | 2023-2025 | Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $216.77 | 2021-2025 | Rexulti, Abilify Maintena |
| Eisai INC. | $147.85 | 2021 | |
| Sunovion Pharmaceuticals INC. | $96.23 | 2021-2022 | |
| Lundbeck LLC | $64.27 | 2021-2025 | Rexulti |
| Alfasigma USA, INC. | $40.49 | 2021 | |
| Axsome Therapeutics, INC. | $36.71 | 2023-2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmoud Moghaddami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.